176 related articles for article (PubMed ID: 26764003)
1. Five of Five VHHs Neutralizing Poliovirus Bind the Receptor-Binding Site.
Strauss M; Schotte L; Thys B; Filman DJ; Hogle JM
J Virol; 2016 Jan; 90(7):3496-505. PubMed ID: 26764003
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action and capsid-stabilizing properties of VHHs with an in vitro antipolioviral activity.
Schotte L; Strauss M; Thys B; Halewyck H; Filman DJ; Bostina M; Hogle JM; Rombaut B
J Virol; 2014 Apr; 88(8):4403-13. PubMed ID: 24501405
[TBL] [Abstract][Full Text] [Related]
3. Cryo-electron Microscopy Structures of Expanded Poliovirus with VHHs Sample the Conformational Repertoire of the Expanded State.
Strauss M; Schotte L; Karunatilaka KS; Filman DJ; Hogle JM
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852863
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Poliovirus Neutralization Escape Mutants of Single-Domain Antibody Fragments (VHHs).
Schotte L; Thys B; Strauss M; Filman DJ; Rombaut B; Hogle JM
Antimicrob Agents Chemother; 2015 Aug; 59(8):4695-706. PubMed ID: 26014941
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.
Shaw J; Jorba J; Zhao K; Iber J; Chen Q; Adu F; Adeniji A; Bukbuk D; Baba M; Henderson E; Dybdahl-Sissoko N; McDonald S; Weldon WC; Gumede N; Oberste MS; Kew OM; Burns CC
J Virol; 2018 May; 92(9):. PubMed ID: 29444940
[TBL] [Abstract][Full Text] [Related]
6. Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry.
Strauss M; Filman DJ; Belnap DM; Cheng N; Noel RT; Hogle JM
J Virol; 2015 Apr; 89(8):4143-57. PubMed ID: 25631086
[TBL] [Abstract][Full Text] [Related]
7. Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor.
Chen Z; Fischer ER; Kouiavskaia D; Hansen BT; Ludtke SJ; Bidzhieva B; Makiya M; Agulto L; Purcell RH; Chumakov K
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20242-7. PubMed ID: 24277851
[TBL] [Abstract][Full Text] [Related]
8. In vitro antiviral activity of single domain antibody fragments against poliovirus.
Thys B; Schotte L; Muyldermans S; Wernery U; Hassanzadeh-Ghassabeh G; Rombaut B
Antiviral Res; 2010 Aug; 87(2):257-64. PubMed ID: 20566349
[TBL] [Abstract][Full Text] [Related]
9. Conformational shift of a major poliovirus antigen confirmed by immuno-cryogenic electron microscopy.
Lin J; Cheng N; Hogle JM; Steven AC; Belnap DM
J Immunol; 2013 Jul; 191(2):884-91. PubMed ID: 23772035
[TBL] [Abstract][Full Text] [Related]
10. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of Junín virus by single domain antibodies targeted against the nucleoprotein.
Linero F; Sepúlveda C; Christopoulou I; Hulpiau P; Scolaro L; Saelens X
Sci Rep; 2018 Jul; 8(1):11451. PubMed ID: 30061671
[TBL] [Abstract][Full Text] [Related]
12. A simple quantitative affinity capturing assay of poliovirus antigens and subviral particles by single-domain antibodies using magnetic beads.
Thys B; Saerens D; Schotte L; De Bleeser G; Muyldermans S; Hassanzadeh-Ghassabeh G; Rombaut B
J Virol Methods; 2011 May; 173(2):300-5. PubMed ID: 21371506
[TBL] [Abstract][Full Text] [Related]
13. Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71.
Zhu L; Xu K; Wang N; Cao L; Wu J; Gao Q; Fry EE; Stuart DI; Rao Z; Wang J; Wang X
mBio; 2018 Jul; 9(4):. PubMed ID: 29970466
[TBL] [Abstract][Full Text] [Related]
14. Structures of Two Human Astrovirus Capsid/Neutralizing Antibody Complexes Reveal Distinct Epitopes and Inhibition of Virus Attachment to Cells.
Ricemeyer L; Aguilar-Hernández N; López T; Espinosa R; Lanning S; Mukherjee S; Cuellar C; López S; Arias CF; DuBois RM
J Virol; 2022 Jan; 96(1):e0141521. PubMed ID: 34613806
[TBL] [Abstract][Full Text] [Related]
15. Allele-specific adaptation of poliovirus VP1 B-C loop variants to mutant cell receptors.
Liao S; Racaniello V
J Virol; 1997 Dec; 71(12):9770-7. PubMed ID: 9371643
[TBL] [Abstract][Full Text] [Related]
16. Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function.
Tremblay JM; Vazquez-Cintron E; Lam KH; Mukherjee J; Bedenice D; Ondeck CA; Conroy MT; Bodt SML; Winner BM; Webb RP; Ichtchenko K; Jin R; McNutt PM; Shoemaker CB
Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32987745
[TBL] [Abstract][Full Text] [Related]
17. Nanobody-Mediated Neutralization Reveals an Achilles Heel for Norovirus.
Koromyslova AD; Devant JM; Kilic T; Sabin CD; Malak V; Hansman GS
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321816
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the poliovirus receptor with poliovirus.
He Y; Bowman VD; Mueller S; Bator CM; Bella J; Peng X; Baker TS; Wimmer E; Kuhn RJ; Rossmann MG
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):79-84. PubMed ID: 10618374
[TBL] [Abstract][Full Text] [Related]
19. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design.
Grant RA; Hiremath CN; Filman DJ; Syed R; Andries K; Hogle JM
Curr Biol; 1994 Sep; 4(9):784-97. PubMed ID: 7820548
[TBL] [Abstract][Full Text] [Related]
20. A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection.
Vrentas CE; Moayeri M; Keefer AB; Greaney AJ; Tremblay J; O'Mard D; Leppla SH; Shoemaker CB
J Biol Chem; 2016 Oct; 291(41):21596-21606. PubMed ID: 27539858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
